APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Drugs and Supplement

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Equine Drugs and Supplement Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchEquine Drugs and Supplement Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Drugs and Supplement Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Equine Drugs and Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Drugs and Supplement Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Drugs and Supplement Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Equine Drugs and Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Equine Drugs and Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Equine Drugs and Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Equine Drugs and Supplement market include Zoetis, Novartis Animal Health, Merck Animal Health, Bayer Animal Health, Merial, Elanco (Eli Lilly) and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Equine Drugs and Supplement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Equine Drugs and Supplement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Drugs and Supplement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equine Drugs and Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

Equine Drugs and Supplement Segment by Company

Zoetis

Novartis Animal Health

Merck Animal Health

Bayer Animal Health

Merial

Elanco (Eli Lilly)

Boehringer Ingelheim

Equine Drugs and Supplement Segment by Type

Stable Isotope

Radioisotope

Equine Drugs and Supplement Segment by Application

Hospital

Laboratory

Others

Equine Drugs and Supplement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Equine Drugs and Supplement status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Equine Drugs and Supplement market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Equine Drugs and Supplement significant trends, drivers, influence factors in global and regions.

6. To analyze Equine Drugs and Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Drugs and Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Drugs and Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Drugs and Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Equine Drugs and Supplement market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Equine Drugs and Supplement industry.

Chapter 3: Detailed analysis of Equine Drugs and Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Equine Drugs and Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Equine Drugs and Supplement in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Equine Drugs and Supplement Industry Trends Table 2. Equine Drugs and Supplement Industry Drivers Table 3. Equine Drugs and Supplement Industry Opportunities and Challenges Table 4. Equine Drugs and Supplement Industry Restraints Table 5. Global Equine Drugs and Supplement Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Equine Drugs and Supplement Revenue Share by Company (2021-2026) Table 7. Global Equine Drugs and Supplement Sales Volume by Company (k units) & (2021-2026) Table 8. Global Equine Drugs and Supplement Sales Volume Share by Company (2021-2026) Table 9. Global Equine Drugs and Supplement Average Price (US$/unit) of Company (2021-2026) Table 10. Global Equine Drugs and Supplement Company Ranking, (2024-2026) & (USD Million) Table 11. Global Equine Drugs and Supplement Key Company Manufacturing Base & Headquarters Table 12. Global Equine Drugs and Supplement Company, Product Type & Application Table 13. Global Equine Drugs and Supplement Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Equine Drugs and Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Stable Isotope Table 18. Significant Companies of Radioisotope Table 19. Global Equine Drugs and Supplement Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Equine Drugs and Supplement Sales Volume by Type (2021-2026) & (k units) Table 21. Global Equine Drugs and Supplement Sales Volume by Type (2027-2032) & (k units) Table 22. Global Equine Drugs and Supplement Sales Volume Share by Type (2021-2026) Table 23. Global Equine Drugs and Supplement Sales Volume Share by Type (2027-2032) Table 24. Global Equine Drugs and Supplement Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Equine Drugs and Supplement Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Equine Drugs and Supplement Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Equine Drugs and Supplement Sales Value Share by Type (2021-2026) Table 28. Global Equine Drugs and Supplement Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Laboratory Table 31. Significant Companies of Others Table 32. Global Equine Drugs and Supplement Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Equine Drugs and Supplement Sales Volume by Application (2021-2026) & (k units) Table 34. Global Equine Drugs and Supplement Sales Volume by Application (2027-2032) & (k units) Table 35. Global Equine Drugs and Supplement Sales Volume Share by Application (2021-2026) Table 36. Global Equine Drugs and Supplement Sales Volume Share by Application (2027-2032) Table 37. Global Equine Drugs and Supplement Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Equine Drugs and Supplement Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Equine Drugs and Supplement Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Equine Drugs and Supplement Sales Value Share by Application (2021-2026) Table 41. Global Equine Drugs and Supplement Sales Value Share by Application (2027-2032) Table 42. Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Equine Drugs and Supplement Sales by Region (2021-2026) & (k units) Table 44. Global Equine Drugs and Supplement Sales Market Share by Region (2021-2026) Table 45. Global Equine Drugs and Supplement Sales by Region (2027-2032) & (k units) Table 46. Global Equine Drugs and Supplement Sales Market Share by Region (2027-2032) Table 47. Global Equine Drugs and Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Equine Drugs and Supplement Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Equine Drugs and Supplement Sales Value Share by Region (2021-2026) Table 50. Global Equine Drugs and Supplement Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Equine Drugs and Supplement Sales Value Share by Region (2027-2032) Table 52. Global Equine Drugs and Supplement Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Equine Drugs and Supplement Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Equine Drugs and Supplement Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Equine Drugs and Supplement Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Equine Drugs and Supplement Sales by Country (2021-2026) & (k units) Table 57. Global Equine Drugs and Supplement Sales Market Share by Country (2021-2026) Table 58. Global Equine Drugs and Supplement Sales by Country (2027-2032) & (k units) Table 59. Global Equine Drugs and Supplement Sales Market Share by Country (2027-2032) Table 60. Global Equine Drugs and Supplement Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Equine Drugs and Supplement Sales Value Market Share by Country (2021-2026) Table 62. Global Equine Drugs and Supplement Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Equine Drugs and Supplement Sales Value Market Share by Country (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Zoetis Equine Drugs and Supplement Product Portfolio Table 68. Zoetis Recent Development Table 69. Novartis Animal Health Company Information Table 70. Novartis Animal Health Business Overview Table 71. Novartis Animal Health Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Animal Health Equine Drugs and Supplement Product Portfolio Table 73. Novartis Animal Health Recent Development Table 74. Merck Animal Health Company Information Table 75. Merck Animal Health Business Overview Table 76. Merck Animal Health Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Animal Health Equine Drugs and Supplement Product Portfolio Table 78. Merck Animal Health Recent Development Table 79. Bayer Animal Health Company Information Table 80. Bayer Animal Health Business Overview Table 81. Bayer Animal Health Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Bayer Animal Health Equine Drugs and Supplement Product Portfolio Table 83. Bayer Animal Health Recent Development Table 84. Merial Company Information Table 85. Merial Business Overview Table 86. Merial Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Merial Equine Drugs and Supplement Product Portfolio Table 88. Merial Recent Development Table 89. Elanco (Eli Lilly) Company Information Table 90. Elanco (Eli Lilly) Business Overview Table 91. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio Table 93. Elanco (Eli Lilly) Recent Development Table 94. Boehringer Ingelheim Company Information Table 95. Boehringer Ingelheim Business Overview Table 96. Boehringer Ingelheim Equine Drugs and Supplement Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio Table 98. Boehringer Ingelheim Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Equine Drugs and Supplement Distributors List Table 102. Equine Drugs and Supplement Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Equine Drugs and Supplement Product Image Figure 2. Global Equine Drugs and Supplement Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 4. Global Equine Drugs and Supplement Sales (2021-2032) & (k units) Figure 5. Global Equine Drugs and Supplement Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Equine Drugs and Supplement Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Stable Isotope Image Figure 10. Radioisotope Image Figure 11. Global Equine Drugs and Supplement Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Equine Drugs and Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Equine Drugs and Supplement Sales Volume Share by Type (2021-2032) Figure 14. Global Equine Drugs and Supplement Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Equine Drugs and Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Equine Drugs and Supplement Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Laboratory Image Figure 19. Others Image Figure 20. Global Equine Drugs and Supplement Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Equine Drugs and Supplement Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Equine Drugs and Supplement Sales Volume Share by Application (2021-2032) Figure 23. Global Equine Drugs and Supplement Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Equine Drugs and Supplement Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Equine Drugs and Supplement Sales Value Share by Application (2021-2032) Figure 26. Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Equine Drugs and Supplement Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Equine Drugs and Supplement Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Equine Drugs and Supplement Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 31. North America Equine Drugs and Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Equine Drugs and Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Equine Drugs and Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 37. South America Equine Drugs and Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Equine Drugs and Supplement Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Equine Drugs and Supplement Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Equine Drugs and Supplement Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Equine Drugs and Supplement Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Equine Drugs and Supplement Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Zoetis
  • Novartis Animal Health
  • Merck Animal Health
  • Bayer Animal Health
  • Merial
  • Elanco (Eli Lilly)
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Equine Drugs and Supplement Sales Value (2021-2032)
  4. 1.2.2 Global Equine Drugs and Supplement Sales Volume (2021-2032)
  5. 1.2.3 Global Equine Drugs and Supplement Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Equine Drugs and Supplement Market Dynamics
  1. 2.1 Equine Drugs and Supplement Industry Trends
  2. 2.2 Equine Drugs and Supplement Industry Drivers
  3. 2.3 Equine Drugs and Supplement Industry Opportunities and Challenges
  4. 2.4 Equine Drugs and Supplement Industry Restraints
3 Equine Drugs and Supplement Market by Company
  1. 3.1 Global Equine Drugs and Supplement Company Revenue Ranking in 2025
  2. 3.2 Global Equine Drugs and Supplement Revenue by Company (2021-2026)
  3. 3.3 Global Equine Drugs and Supplement Sales Volume by Company (2021-2026)
  4. 3.4 Global Equine Drugs and Supplement Average Price by Company (2021-2026)
  5. 3.5 Global Equine Drugs and Supplement Company Ranking (2024-2026)
  6. 3.6 Global Equine Drugs and Supplement Company Manufacturing Base and Headquarters
  7. 3.7 Global Equine Drugs and Supplement Company Product Type and Application
  8. 3.8 Global Equine Drugs and Supplement Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Equine Drugs and Supplement Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Equine Drugs and Supplement Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Equine Drugs and Supplement Market by Type
  1. 4.1 Equine Drugs and Supplement Type Introduction
  2. 4.1.1 Stable Isotope
  3. 4.1.2 Radioisotope
  4. 4.2 Global Equine Drugs and Supplement Sales Volume by Type
  5. 4.2.1 Global Equine Drugs and Supplement Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Equine Drugs and Supplement Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Equine Drugs and Supplement Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Equine Drugs and Supplement Sales Value by Type
  9. 4.3.1 Global Equine Drugs and Supplement Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Equine Drugs and Supplement Sales Value by Type (2021-2032)
  11. 4.3.3 Global Equine Drugs and Supplement Sales Value Share by Type (2021-2032)
5 Equine Drugs and Supplement Market by Application
  1. 5.1 Equine Drugs and Supplement Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Equine Drugs and Supplement Sales Volume by Application
  6. 5.2.1 Global Equine Drugs and Supplement Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Drugs and Supplement Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Equine Drugs and Supplement Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Equine Drugs and Supplement Sales Value by Application
  10. 5.3.1 Global Equine Drugs and Supplement Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Equine Drugs and Supplement Sales Value by Application (2021-2032)
  12. 5.3.3 Global Equine Drugs and Supplement Sales Value Share by Application (2021-2032)
6 Equine Drugs and Supplement Regional Sales and Value Analysis
  1. 6.1 Global Equine Drugs and Supplement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Drugs and Supplement Sales by Region (2021-2032)
  3. 6.2.1 Global Equine Drugs and Supplement Sales by Region: 2021-2026
  4. 6.2.2 Global Equine Drugs and Supplement Sales by Region (2027-2032)
  5. 6.3 Global Equine Drugs and Supplement Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Equine Drugs and Supplement Sales Value by Region (2021-2032)
  7. 6.4.1 Global Equine Drugs and Supplement Sales Value by Region: 2021-2026
  8. 6.4.2 Global Equine Drugs and Supplement Sales Value by Region (2027-2032)
  9. 6.5 Global Equine Drugs and Supplement Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Equine Drugs and Supplement Sales Value (2021-2032)
  12. 6.6.2 North America Equine Drugs and Supplement Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Equine Drugs and Supplement Sales Value (2021-2032)
  15. 6.7.2 Europe Equine Drugs and Supplement Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Equine Drugs and Supplement Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Equine Drugs and Supplement Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Equine Drugs and Supplement Sales Value (2021-2032)
  21. 6.9.2 South America Equine Drugs and Supplement Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Equine Drugs and Supplement Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Equine Drugs and Supplement Sales Value Share by Country, 2025 VS 2032
7 Equine Drugs and Supplement Country-level Sales and Value Analysis
  1. 7.1 Global Equine Drugs and Supplement Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Equine Drugs and Supplement Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Equine Drugs and Supplement Sales by Country (2021-2032)
  4. 7.3.1 Global Equine Drugs and Supplement Sales by Country (2021-2026)
  5. 7.3.2 Global Equine Drugs and Supplement Sales by Country (2027-2032)
  6. 7.4 Global Equine Drugs and Supplement Sales Value by Country (2021-2032)
  7. 7.4.1 Global Equine Drugs and Supplement Sales Value by Country (2021-2026)
  8. 7.4.2 Global Equine Drugs and Supplement Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Equine Drugs and Supplement Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Equine Drugs and Supplement Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Equine Drugs and Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Equine Drugs and Supplement Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Novartis Animal Health
  8. 8.2.1 Novartis Animal Health Company Information
  9. 8.2.2 Novartis Animal Health Business Overview
  10. 8.2.3 Novartis Animal Health Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Animal Health Equine Drugs and Supplement Product Portfolio
  12. 8.2.5 Novartis Animal Health Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Equine Drugs and Supplement Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Bayer Animal Health
  20. 8.4.1 Bayer Animal Health Company Information
  21. 8.4.2 Bayer Animal Health Business Overview
  22. 8.4.3 Bayer Animal Health Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Animal Health Equine Drugs and Supplement Product Portfolio
  24. 8.4.5 Bayer Animal Health Recent Developments
  25. 8.5 Merial
  26. 8.5.1 Merial Company Information
  27. 8.5.2 Merial Business Overview
  28. 8.5.3 Merial Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merial Equine Drugs and Supplement Product Portfolio
  30. 8.5.5 Merial Recent Developments
  31. 8.6 Elanco (Eli Lilly)
  32. 8.6.1 Elanco (Eli Lilly) Company Information
  33. 8.6.2 Elanco (Eli Lilly) Business Overview
  34. 8.6.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco (Eli Lilly) Equine Drugs and Supplement Product Portfolio
  36. 8.6.5 Elanco (Eli Lilly) Recent Developments
  37. 8.7 Boehringer Ingelheim
  38. 8.7.1 Boehringer Ingelheim Company Information
  39. 8.7.2 Boehringer Ingelheim Business Overview
  40. 8.7.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Boehringer Ingelheim Equine Drugs and Supplement Product Portfolio
  42. 8.7.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Equine Drugs and Supplement Value Chain Analysis
  2. 9.1.1 Equine Drugs and Supplement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Equine Drugs and Supplement Sales Mode & Process
  6. 9.2 Equine Drugs and Supplement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Equine Drugs and Supplement Distributors
  9. 9.2.3 Equine Drugs and Supplement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst